secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kymera Therapeutics, Inc. (KYMR)
CIK:        0001815442
Form:       8-K
Filed at:   2025-06-27T23:59:59+00:00
Accession:  0001193125-25-151345
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Kymera shareholders elect Albers and Baker as Class II directors at 2025 annual meeting
--------------------------------------------------------------------------------

- Jeffrey Albers elected with 55,765,189 votes for, 3,142,251 withheld.
- Felix J. Baker elected with 51,745,887 votes for, 7,161,553 withheld.
- Advisory say-on-pay resolution approved: 54,364,880 for, 4,531,413 against.
- Ernst & Young ratified as independent auditor for FY2025 with 61,644,725 votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815442/000119312525151345/0001193125-25-151345-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815442/000119312525151345/d87067d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-151345

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer